News ID: 313974
Published: 0905 GMT June 17, 2021

Iran, India to jointly produce ‘Rotavirus’ vaccine

Iran, India to jointly produce ‘Rotavirus’ vaccine
MNA

Iran and India have agreed to cooperate in the field of transferring technical knowhow and jointly producing ‘Rotavirus’ vaccine in Iran.

The agreement was signed on Wednesday between the Institute Pasteur of Iran (PII) and India’s Bharat Biotech Vaccine Manufacturing Company during a webinar held in the presence of presidents of Pasteur Institute of Iran and India’s Bharat Biotech Vaccine Manufacturing Company, Mehr News Agency reported.

Rotavirus is the most common cause of severe diarrhea in children, and almost every child becomes infected at least once before the age of five.

It is estimated that more than 500,000 children under the age of 5 die each year by Rotavirus.

Based on the agreement, a contract was inked between the two sides in order to supply ‘Rotavirus’ vaccine for being used in domestic vaccination system and also transfer of technology for domestic production of the vaccine in Iran.

The ambassadors of both countries, as well as officials from the ministries of health and foreign affairs of Iran and India, were also present at the virtual meeting.

   
KeyWords
 
Resource: MNA
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/1948 sec